Conference Nordic HPB - NOLCA, AARHUS

24 – 25 September 2026

Thursday September 24 - NORDIC HPB

08.30 - 09.00 Registration and coffee

09.00 - 09.10 Welcome by President Roland Andersson and Local Organizing Committee

SESSION 1 PANCREAS Chair: Stefan Burgdorf (Copenhagen) & Ernesto Sparrelid (Stockholm)

09.10 - 09.25 Pancreatic cysts – a less restrictive approach, Martin Graversen, Copenhagen

09.25 - 09.40 Chemotherapy for (borderline) resectable pancreatic cancer, Knut Jørgen Labori, Oslo

09.40 - 09.55 Arterial resections in pancreatic cancer surgery – a nationwide perspective, Claus Fristrup, Odense

09.55 - 10.05 Early diagnosis of pancreatic cancer in new-onset diabetes, Anna Brodén, Lund

10.05 - 10.15 Upfront surgery for jaundiced pancreatic cancer patients, Dominique Lisa Birrer, Stockholm

10.15 - 10.45 Coffee break and exhibition

SESSION 2 PERIOPERATIVE MANAGEMENT IN HPB SURGERY

Chair: Frank Mortensen (Aarhus) & Roland Andersson (Lund)

10.45 - 11.15 State-of-the-art presentation: ERAS, Henrik Kehlet, Copenhagen

11.15 - 11.45 How to achieve textbook outcome in HPB surgery? Flavio Rocha, Portland

11.45 - 12.00 Perioperative management from a nursing perspective, Ida Hovdenak, Aarhus

12.00 - 12.15 Timing of surgery and neoadjuvant chemotherapy in HPB cancers, Arne Westgaard, Oslo

12.15 - 12.30 Panel discussion. How can we further improve perioperative outcomes? All speakers from Session 2

12.30 - 13.30 Lunch and exhibition

SESSION 3 STATE-OF-THE-ART ERCP – HOW TO ACHIEVE OPTIMAL OUTCOMES?

Chair: Anja Bjørnskov (Aarhus) & Jenny Rystedt (Lund)

13.30 - 13.40 Volume-outcomes associations, Nikolaj Sølvsten, Aarhus

13.40 - 13.50 The Danish perspective, John Karstensen, Hvidovre

13.50 - 14.00 The Norwegian perspective, Kim Vidar Ånonsen, Oslo

14.00 - 14.10 The Swedish perspective, Fredrik Swahn, Stockholm

14.10 - 14.20 The Finnish perspective, Reea Ahola, Tampere

14.20 - 14.30 Panel discussion by All speakers from Session 3

‍ ‍

POSTER WALK – JOINT NORDIC HPB AND NOLCA

Chair: Anders Knudsen (Aarhus), Aiste Kielaite -Gulla (Lithuania) & Peter Jepsen (Aarhus)

14.30 - 15.00 Poster walk and networking

15.00 - 15.30 Coffee break and exhibition

FREE PAPERS

Chair: Oskar Franklin (Umeå) & Hanna Seppänen (Helsinki)

15.30-16.00

Each presentation is 6 minutes followed by 2 minutes of Q&A

 ASAc study results, Sheraz Yaqub, Oslo

Micro-CT analysis can distinguish features of PDAC: preliminary experience, Kaisa Tyrväinen, Tampere

Adult choledochal cyst resection in Scandinavia: malignancy prevalence and morbidity in a multicentre surgical cohort, Sondre Busund, Oslo

Systematic Implementation of High-Level Evidence: Introducing a No-drain Policy after Left Pancreatectomy, Trond Kjeseth, Stavanger

GENERAL SESSION

Chair: Jakob Kirkegård (Aarhus) & Sheraz Yaqub (Oslo)

16.00 - 16.10 Presidential address by President Roland Andersson, Lund

16.10 - 16.20 The Nordic-Baltic collaboration: Status and future perspectives, Aiste Kielaite-Gulla, Lithuania

16.20 - 16.45 Ideas for Collaboration (short presentations, 2 minutes each – 3 minutes for questions – further discussions during the coffee break or dinner)

- PanDelay: Delayed adjuvant therapy in pancreatic cancer (Caroline Vilhav)

- SINISTRA: Neoadjuvant chemotherapy for left-sided pancreatic cancer (Hanna Seppänen)

- NordFHPC: Nordic Familial and Hereditary Pancreatic Cancer Consortium (Sini Keskinen)

- MORIP-STAR: Arterial and multivisceral resections in pancreatic cancer (Paulina Bereza-Carlson)

- PRE-PAN: Pre-operative optimization in pancreatic cancer surgery (Emma Hyldgaard Olesen)

16.45 - 17.00 Most important HPB papers 2025-2026, Kjetil Søreide, Gothenburg

17.00 - 17.15 General Assembly, Nordic HPB for All Nordic HPB members

Friday, September 25 - NOLCA & NORDIC HPB

08.00 - 08.30 Registration and coffee

NOLCA:  HEPATOCELLULAR CARCINOMA

Chair: Merete Krogh (Odense) & Peter Jepsen (Aarhus)

08.30 - 08.35 Welcome by NOLCA President Pia Österlund, Espo

08.35 -09.20 The BCLC is for HCC experts what Camp Nou is for football experts: decades of world-class performance, Maria Reig, Barcelona, introduced by Gerda E. Villadsen

09.20 - 09.35 Two oral presentations selected among submitted abstracts

Survival across multidisciplinary team-driven treatment plans in patients with hepatocellular carcinoma, Aneeka Deen, Copenhagen

A National Phase II Study of Proton Therapy in Hepatocellular Carcinoma: Short-Term Safety Data, Amalie Bjørn, Aarhus

09.35-10.00 Coffee break and exhibition

NOLCA: ABLATION AND LIVER TRANSPLANTATION

Chair: Per Stål (Stockholm) & Bård Røsok (Oslo)

10.00-10.45 State of the art of liver tumor ablation, Ingrid Schrøder Hansen and Daniel Östergaard, Oslo

10.45 - 11.30 Liver transplantation for intrahepatic cholangiocarcinoma, Andreas Schult, Gothenburg

11.30 - 11.45 General Assembly for all NOLCA members

11.45 - 12.45 Lunch and exhibition

SESSION 4 LIVER

‍ ‍Chair:Gerda E. Villadsen (Aarhus) & Kirsten Vistisen( Herlev)

12.45-13.00 HAI – the Portland experience, Skye C. Mayo, Portland

13.00-13.20 Borderline cases and downstaging strategies in cirrhotic patients, Sheraz Yaqub, Oslo

13.20-13.40 Augmentation in cirrhotic patients, Minna Nortunen, Oulu

13.40-14.00 Functional assessment before resection in cirrhotic patients, Christoph Tschuor, Copenhagen

14.00-14.20 Oncologic criteria for resectability in cirrhotic patients, Anders Knudsen, Aarhus

14.20 - 14.30 Panel discussion, All speakers

14.30 - 14.45 Closing remarks, prizes and goodbyes (joint session for Nordic HPB, NOLCA, and Nurses) by Nordic HPB President Roland Andersson & Local Organizing Committee